Peptide antibiotics: an alternative and effective antimicrobial strategy to circumvent fungal infections.
Mycosis, caused by both filamentous fungi and pathogenic yeasts is a major concern nowadays especially in the immunocompromised patient population. The emergence of pathogenic fungi resistant to current therapies in the last few decades has intensified the search for new antifungals like cationic peptides, which are the key components of innate defense mechanism. The review provides an inventory of different peptides from a diverse array of organisms from bacteria to mammals with proven antifungal activity, their therapeutic options and also about those which are in various stages of preclinical development. Literature, on the total and semi-synthetic variants of the parent peptides that exhibit an improved antifungal activity is also reviewed.
Department of Biotechnology and Microbiology, Kannur University, Kerala, India.
K
K
Ajesh
K
K
Sreejith
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000517:prevention & control; D010455:Peptides / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D010455:Peptides